Medirom healthcare technologies inc. announces preliminary, unaudited financial results for full year 2022 under japanese gaap

New york--( business wire )--medirom healthcare technologies inc. (nasdaq cm: mrm), a holistic healthcare company based in japan (the “company”), today announced its preliminary, unaudited financial results for the year ended december 31, 2022, prepared under japanese gaap (“jgaap”). these preliminary financial results and management's estimates included in this press release are unreviewed, unaudited, and preliminary, are prepared solely in accordance with jgaap, have not been reviewed or audited under u.s. gaap, and are based solely on information available to the management of the company and management's assumptions and expectations as of the date of this press release, which remain subject to change. actual results for the year ended december 31, 2022 remain subject to the completion of management's reviews and reconciliations and/or adjustments under u.s. gaap, the company's other financial closing procedures, and the audit by the independent auditor in accordance with u.s. gaap, and may differ from these estimated preliminary results due to the completion of the company's financial closing procedures, the audit under u.s. gaap, and other developments that may arise during the audit process. accordingly, you should not place undue reliance on this preliminary information. see “important notice regarding these preliminary financial results and management's estimates” below.
MRM Ratings Summary
MRM Quant Ranking